NCT04341337

Brief Summary

  • The surgical device used to perform PIPAC procedure is commercialized by a single manufacturer under a monopoly regimen, and a formal training (economically supported by the manufacturer) is mandatory for surgeons who want to buy the device.Relations with the company and solutions to extend training require specific analysis from an ethical point of view.
  • Based on the growing number of published papers from a growing number of international centers, the controlled training model is not limiting, and it is a successful model of development of this breakthrough innovation.
  • But with the major involvement of the industry and the control of training, the different levels of interest could induce ethical questions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 2, 2019

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 6, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 6, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 6, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 10, 2020

Completed
Last Updated

April 29, 2020

Status Verified

April 1, 2020

Enrollment Period

1.1 years

First QC Date

April 6, 2020

Last Update Submit

April 27, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • qualitative analysis of the interviews

    Questions for interviews were first prepared. Six questions for the clinicians and the scientist were elaborated about the interviewees' experience concerning the initiation and use of PIPAC, difficulties encountered to initiate this activity in their respective centres, description of the involvement of the industry for the development of the technique, the clinician-industry relationship, the mandatory nature of the training, and their ethical judgment on this model. For the biomedical manager, questions were about the set-up of the PIPAC procedure and the implication of the industry in the process. The commercial representative was interviewed about the business strategy of the industry. The interviewer had the freedom to adapt questions to prior answers. Interviewees did not receive the questionnaire before the discussion.

    1 month

Study Arms (1)

expert

interviews of expert of pipac about ethical issues

Other: interview

Interventions

questionnaire about ethics in surgery

expert

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

expert working in academic tertiary center

You may qualify if:

  • expert in pipac
  • more than 30 PIPAC per year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Université de Paris

Paris, 75011, France

Location

Related Publications (1)

  • Martellotto S, Maillot C, Villeneuve L, Eveno C, Sgarbura O, Pocard M. Restricted access to innovative surgical technique related to a specific training, is it ethical? Example of the PIPAC procedure. A systematic review and an experts survey. Int J Surg. 2020 Nov;83:235-245. doi: 10.1016/j.ijsu.2020.07.004. Epub 2020 Jul 29.

MeSH Terms

Conditions

Peritoneal Neoplasms

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Abdominal NeoplasmsNeoplasms by SiteNeoplasmsDigestive System NeoplasmsDigestive System DiseasesPeritoneal Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

April 6, 2020

First Posted

April 10, 2020

Study Start

March 2, 2019

Primary Completion

April 6, 2020

Study Completion

April 6, 2020

Last Updated

April 29, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations